Pendal Global Emerging Mkts Oppes – WS is an Managed Funds investment product that is benchmarked against World Emerging Markets Index and sits inside the Foreign Equity - Emerging Markets Index. Think of a benchmark as a standard where investment performance can be measured. Typically, market indices like the ASX200 and market-segment stock indexes are used for this purpose. The Pendal Global Emerging Mkts Oppes – WS has Assets Under Management of 179.40 M with a management fee of 1.18%, a performance fee of 0.00% and a buy/sell spread fee of 0.61%.
The recent investment performance of the investment product shows that the Pendal Global Emerging Mkts Oppes – WS has returned 5.27% in the last month. The previous three years have returned 2.85% annualised and 11.05% each year since inception, which is when the Pendal Global Emerging Mkts Oppes – WS first started.
There are many ways that the risk of an investment product can be measured, and each measurement provides a different insight into the risk present. They can be used on their own or together to perform a risk assessment before investing, but when comparing investments, it is common to compare like for like risk measurements to determine which investment holds the most risk. Since Pendal Global Emerging Mkts Oppes – WS first started, the Sharpe ratio is NA with an annualised volatility of 11.05%. The maximum drawdown of the investment product in the last 12 months is -3.62% and -20.28% since inception. The maximum drawdown is defined as the high-to-low decline of an investment during a particular time period.
Relative performance is what an asset achieves over a period of time compared to similar investments or its peers. Relative return is a measure of the asset's performance compared to the return to the other investment. The Pendal Global Emerging Mkts Oppes – WS has a 12-month excess return when compared to the Foreign Equity - Emerging Markets Index of -2.54% and -0.2% since inception.
Alpha is an investing term used to measure an investment's outperformance relative to a market benchmark or peer investment. Alpha describes the excess return generated when compared to peer investment. Pendal Global Emerging Mkts Oppes – WS has produced Alpha over the Foreign Equity - Emerging Markets Index of NA% in the last 12 months and NA% since inception.
For a full list of investment products in the Foreign Equity - Emerging Markets Index category, you can click here for the Peer Investment Report.
Pendal Global Emerging Mkts Oppes – WS has a correlation coefficient of 0.89 and a beta of 1.34 when compared to the Foreign Equity - Emerging Markets Index. Correlation measures how similarly two investments move in relation to one another. This establishes a 'correlation coefficient', which has a value between -1.0 and +1.0. A 100% correlation between two investments means that the correlation coefficient is +1. Beta in investments measures how much the price moves relative to the broader market over a period of time. If the investment moves more than the broader market, it has a beta above 1.0. If it moves less than the broader market, then the beta is less than 1.0. Investments with a high beta tend to carry more risk but have the potential to deliver higher returns.
For a full quantitative report on Pendal Global Emerging Mkts Oppes – WS and its peer investments, you can click here for the Peer Investment Report.
For a full quantitative report on Pendal Global Emerging Mkts Oppes – WS compared to the World Emerging Markets Index, you can click here.
To sort and compare the Pendal Global Emerging Mkts Oppes – WS financial metrics, please refer to the table above.
This investment product is in the process of being independently verified by SMSF Mate. Once we have verified the investment product, you will be able to find more information here.
SMSF Mate does not receive commissions or kickbacks from the Pendal Global Emerging Mkts Oppes – WS. All data and commentary for this fund is provided free of charge for our readers general information.
This Fund is designed for investors who want the potential for long-term capital growth, diversification across a broad range of global emerging market shares and are prepared to accept high variability of returns. The Fund can invest in shares in a range of emerging markets and may also hold cash.
As manager of the Fund, J O Hambro Capital Management (JOHCM) investment process for global emerging market shares aims to add value through a combination of country allocation as well as individual stock selection. JOHCM’s country allocation process is based on analysis of a country’s economic growth, monetary policy, market liquidity, currency, governance/politics and equity market valuation. The stock selection process focuses on buying quality growth stocks at attractive valuations.
This Fund is designed for investors who want the potential for long-term capital growth, diversification across a broad range of global emerging market shares and are prepared to accept high variability of returns. The Fund can invest in shares in a range of emerging markets and may also hold cash.
As manager of the Fund, J O Hambro Capital Management (JOHCM) investment process for global emerging market shares aims to add value through a combination of country allocation as well as individual stock selection. JOHCM’s country allocation process is based on analysis of a country’s economic growth, monetary policy, market liquidity, currency, governance/politics and equity market valuation. The stock selection process focuses on buying quality growth stocks at attractive valuations
This Fund is designed for investors who want the potential for long-term capital growth, diversification across a broad range of global emerging market shares and are prepared to accept high variability of returns. The Fund can invest in shares in a range of emerging markets and may also hold cash. As manager of the Fund, J O Hambro Capital Management (JOHCM) investment process for global emerging market shares aims to add value through a combination of country allocation as well as individual stock selection. JOHCM’s country allocation process is based on analysis of a country’s economic growth, monetary policy, market liquidity, currency, governance/politics and equity market valuation. The stock selection process focuses on buying quality growth stocks at attractive valuations.
This Fund is designed for investors who want the potential for long-term capital growth, diversification across a broad range of global emerging market shares and are prepared to accept high variability of returns. The Fund can invest in shares in a range of emerging markets and may also hold cash.
As manager of the Fund, J O Hambro Capital Management (JOHCM) investment process for global emerging market shares aims to add value through a combination of country allocation as well as individual stock selection. JOHCM’s country allocation process is based on analysis of a country’s economic growth, monetary policy, market liquidity, currency, governance/politics and equity market valuation. The stock selection process focuses on buying quality growth stocks at attractive valuations
The portfolio underperformed over the month with stock selection, primarily in China, weighing on relative returns. Here, the portfolio suffered from not owning the likes of Tencent (we maintain exposure through Naspers), Alibaba, and Meituan. Our holding in Xinyi Solar was also weak. Our Indian names added value although the top performers were Hong Kong Exchanges, Naspers and Prosus.
We have a steadily evolving interest in the traditionally higher-beta emerging markets, seeing domestic recoveries that have a good distance to run based on current trade balances and on the reset to credit and demand cycles that 2020 created. Also supporting those trade balances are some powerful upward moves in terms of trade (the ratio of export prices to import prices) in some of these economies. Of particular note, is India. After the weak economic environment seen in 2019 and then the effects of the Covid-19 lockdowns, India has seen a powerful demand recovery in recent months. PMIs have generally been printing at above 55 and vehicle sales remain strong. The recovery began into the autumn festive season, and companies were unsure if it would last, but it has. In particular, companies are reporting strong demand and a reduced need to fund promotion and associated expenses to generate sales. Driving the recovery has been urban demand (which slowed in 2019 and 2020, even for FMCG companies, but which has revived as Coivd-19 cases continue to fall), premium segments (as disposable incomes and consumer confidence improve), and real estate (helped by lower mortgage rates and improved affordability).
The portfolio outperformed in December with our top-down country allocation calls the main driver of relative returns. Our significant overweight position in South Korea and underweight in China proved particularly beneficial, as did our portfolio void in Alibaba.
As both the country first into the 2020 Covid crisis, and one of the (predominantly Asia-Pacific) countries that has seemed to manage the pandemic well, China was the first emerging market to show economic recovery in mid-2020. At the present time, however, we see some challenges to Chinese equities, and have responded by reducing our weight in the country, especially in the light of some of the highly attractive opportunities we find in other markets.
First of these challenges are the signs of a slowdown in Chinese activity in the last quarter of 2020. The other set of challenges concern politics and policy, both within China and internationally. Domestically, the fallout continues from Alibaba founder Jack Ma’s speech in October in which he criticised Chinese regulators. This has happened at broadly the same time as the US government has been ratcheting up restrictions on US investors investing in Chinese state-owned enterprises, principally by targeting the US secondary listings of such companies.
We had already reduced exposure to US-listed Chinese SOEs in the portfolio in 2020, selling CNOOC, Sinopec and China Mobile. We have further reduced our weighting in China, partly in response to the various concerns highlighted above, and also partly in response to the much better macro environments we find in some other emerging markets.
The portfolio performed somewhat in-line with the benchmark over the month. Our underweight in China and overweight in South Korea added value, as did our Indian holdings. In China, our portfolio void in Alibaba was helpful after the suspension of Ant Financial’s highly anticipated IPO. Although stock selection effects were modestly positive, some of our non-benchmark holdings, namely Barrick Gold, weighed on returns. Barrick Gold was the main laggard as the gold price dipped on the back of more risk-on sentiment as positive vaccine data boosted optimism.
Much of the commentary around the impact of the coronavirus on economies around the world has emphasised the unprecedented nature of the crisis. The outcome, though, is in some senses not new to emerging markets. Sudden, brutal hard stops in domestic consumption and activity, accompanied by capital flight and spectacular correlated sell-offs in equities and currencies, have been a sporadic feature of the asset class since at least the Latin American debt crisis of the early 1980s. That pattern allows us to look for signs as to which economies (and, potentially, markets) are in the best positions to recover.
There are particular indicators that, in our experience, show an economy at least has the foundations of a recovery in place, although history suggests it is usually worth looking for positive momentum in economic indicators and corporate results/expectations as well. Looking at these indicators, two markets stand out as particularly interesting right now: India and South Africa.
Product Snapshot
Product Overview
Performance Review
Peer Comparison
Product Details